Broad-based market gains - AxoGen cited strong growth across Extremities, Oral Maxillofacial & Head and Neck, and Breast segments, supported by more than 20% year-over-year account productivity.
Sales force and insurance coverage - The company attributed results to expanded sales force coverage and improved commercial insurance coverage and payment.
Quarterly results
Peripheral nerve repair firm AxoGen said second-quarter revenue rose 23% year over year, beating analyst expectations.
Adjusted EPS for the quarter met analyst expectations.
The company cited broad-based growth across target markets, led by breast procedures.
AXGN•
